• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The antiviral prophylaxis of post-transplant lymphoproliferative disorder.

作者信息

Davis C L

机构信息

Division of Nephrology and Transplantation Services, University of Washington Medical Center, Seattle 98195-6174, USA.

出版信息

Springer Semin Immunopathol. 1998;20(3-4):437-53. doi: 10.1007/BF00838054.

DOI:10.1007/BF00838054
PMID:9870256
Abstract
摘要

相似文献

1
The antiviral prophylaxis of post-transplant lymphoproliferative disorder.移植后淋巴增生性疾病的抗病毒预防
Springer Semin Immunopathol. 1998;20(3-4):437-53. doi: 10.1007/BF00838054.
2
A randomized trial of ganciclovir versus ganciclovir plus immune globulin for prophylaxis against Epstein-Barr virus related posttransplant lymphoproliferative disorder.一项比较更昔洛韦与更昔洛韦加免疫球蛋白预防爱泼斯坦-巴尔病毒相关移植后淋巴细胞增生性疾病的随机试验。
Transplantation. 2006 Mar 27;81(6):856-61. doi: 10.1097/01.tp.0000202724.07714.a2.
3
Role of donor versus recipient type Epstein-Barr virus in post-transplant lymphoproliferative disorders.供体与受体类型的爱泼斯坦-巴尔病毒在移植后淋巴细胞增生性疾病中的作用。
Springer Semin Immunopathol. 1998;20(3-4):375-87. doi: 10.1007/BF00838050.
4
The role of antiviral and immunoglobulin therapy in the prevention of Epstein-Barr virus infection and post-transplant lymphoproliferative disease following solid organ transplantation.抗病毒和免疫球蛋白疗法在实体器官移植后预防爱泼斯坦-巴尔病毒感染及移植后淋巴细胞增殖性疾病中的作用。
Transpl Infect Dis. 2001 Jun;3(2):97-103. doi: 10.1034/j.1399-3062.2001.003002097.x.
5
Posttransplant lymphoproliferative disease.移植后淋巴细胞增生性疾病
Pediatr Infect Dis J. 2005 Dec;24(12):1107-8. doi: 10.1097/00006454-200512000-00017.
6
Prevention of Posttransplant Lymphoproliferative Disorder in Pediatric Patients With a Liver Transplant.小儿肝移植受者移植后淋巴细胞增生性疾病的预防
Exp Clin Transplant. 2015 Oct;13(5):426-9. doi: 10.6002/ect.2013.0193. Epub 2014 Sep 17.
7
Epstein-Barr virus: evasive maneuvers in the development of PTLD.爱泼斯坦-巴尔病毒：移植后淋巴组织增生性疾病发展中的规避策略
Am J Transplant. 2007 Feb;7(2):271-7. doi: 10.1111/j.1600-6143.2006.01650.x. Epub 2007 Jan 4.
8
Relative EBV antibody concentrations and cost of standard IVIG and CMV-IVIG for PTLD prophylaxis in solid organ transplant patients.实体器官移植患者中用于预防移植后淋巴组织增生性疾病（PTLD）的相对EB病毒抗体浓度以及标准静脉注射免疫球蛋白（IVIG）和巨细胞病毒免疫球蛋白（CMV-IVIG）的成本。
Pediatr Transplant. 2014 Sep;18(6):599-601. doi: 10.1111/petr.12315. Epub 2014 Jul 7.
9
Control of Epstein-Barr virus load and lymphoproliferative disease by maintenance of CD8+ T lymphocytes in the T lymphocyte-depleted graft after bone marrow transplantation.
J Infect Dis. 2004 Nov 1;190(9):1596-9. doi: 10.1086/424602. Epub 2004 Sep 21.
10
Prevention and treatment of Epstein-Barr virus-associated lymphoproliferative disorders in recipients of bone marrow and solid organ transplants.骨髓和实体器官移植受者中爱泼斯坦-巴尔病毒相关淋巴增殖性疾病的预防与治疗
Br J Haematol. 2002 Dec;119(3):596-607. doi: 10.1046/j.1365-2141.2002.03887.x.

引用本文的文献

1
An MHV-68 Mutator Phenotype Mutant Virus, Confirmed by CRISPR/Cas9-Mediated Gene Editing of the Viral DNA Polymerase Gene, Shows Reduced Viral Fitness.CRISPR/Cas9 介导的病毒 DNA 聚合酶基因编辑确认的 MHV-68 突变表型突变病毒显示病毒适应性降低。
Viruses. 2021 May 26;13(6):985. doi: 10.3390/v13060985.
2
Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy.化疗后无发热性中性粒细胞减少患者细菌感染的抗生素预防
Cochrane Database Syst Rev. 2012 Jan 18;1(1):CD004386. doi: 10.1002/14651858.CD004386.pub3.
3
Pediatric post-transplant lymphoproliferative disorder after cardiac transplantation.

本文引用的文献

1
Posttransplantation lymphoproliferative disorder associated with OKT3 and decreased antiviral prophylaxis in pancreas transplant recipients.
Clin Infect Dis. 1998 Mar;26(3):596-600. doi: 10.1086/514579.
2
Prophylactic oral ganciclovir compared with deferred therapy for control of cytomegalovirus in renal transplant recipients.预防性口服更昔洛韦与延迟治疗对肾移植受者巨细胞病毒的控制效果比较
Transplantation. 1997 Dec 27;64(12):1843-6. doi: 10.1097/00007890-199712270-00036.
3
Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. The Oral Ganciclovir International Transplantation Study Group [corrected].口服更昔洛韦预防肝移植受者巨细胞病毒病疗效和安全性的随机试验。口服更昔洛韦国际移植研究组[校正后]
心脏移植后小儿移植后淋巴细胞增生性疾病
Int J Hematol. 2009 Sep;90(2):127-136. doi: 10.1007/s12185-009-0399-x. Epub 2009 Aug 12.
4
The role of EBV in post-transplant malignancies: a review.EBV在移植后恶性肿瘤中的作用：综述
J Clin Pathol. 2000 Apr;53(4):248-54. doi: 10.1136/jcp.53.4.248.
Lancet. 1997 Dec 13;350(9093):1729-33. doi: 10.1016/s0140-6736(97)05535-9.
4
Reduced incidence of Epstein-Barr virus-associated posttransplant lymphoproliferative disorder using preemptive antiviral therapy.采用抢先抗病毒治疗降低爱泼斯坦-巴尔病毒相关移植后淋巴细胞增生性疾病的发病率。
Transplantation. 1997 Sep 27;64(6):848-52. doi: 10.1097/00007890-199709270-00010.
5
Prognostic value of serum interleukin-6 in diffuse large-cell lymphoma.
Ann Intern Med. 1997 Aug 1;127(3):186-94. doi: 10.7326/0003-4819-127-3-199708010-00002.
6
Prophylaxis of cytomegalovirus infection in liver transplantation: a randomized trial comparing a combination of ganciclovir and acyclovir to acyclovir. NIDDK Liver Transplantation Database.肝移植中巨细胞病毒感染的预防：一项比较更昔洛韦与阿昔洛韦联合用药和阿昔洛韦的随机试验。美国国立糖尿病、消化和肾脏疾病研究所肝移植数据库。
Transplantation. 1997 Jul 15;64(1):66-73. doi: 10.1097/00007890-199707150-00013.
7
Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders.使用定量竞争性聚合酶链反应测量患有淋巴增生性疾病的儿科移植患者外周血中爱泼斯坦-巴尔病毒基因组载量。
J Clin Microbiol. 1997 Jun;35(6):1612-5. doi: 10.1128/jcm.35.6.1612-1615.1997.
8
Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial.静脉注射西多福韦治疗艾滋病患者外周巨细胞病毒性视网膜炎。一项随机对照试验。
Ann Intern Med. 1997 Feb 15;126(4):257-63. doi: 10.7326/0003-4819-126-4-199702150-00001.
9
Epstein-Barr virus LMP1 induction of the epidermal growth factor receptor is mediated through a TRAF signaling pathway distinct from NF-kappaB activation.爱泼斯坦-巴尔病毒潜伏膜蛋白1对表皮生长因子受体的诱导作用是通过一条不同于核因子κB激活的肿瘤坏死因子受体相关因子信号通路介导的。
J Virol. 1997 Jan;71(1):586-94. doi: 10.1128/JVI.71.1.586-594.1997.
10
Post-transplantation lymphoproliferative disorder in the Epstein-Barr virus-naïve lung transplant recipient.初次感染爱泼斯坦-巴尔病毒的肺移植受者的移植后淋巴细胞增生性疾病
Am J Respir Crit Care Med. 1996 Dec;154(6 Pt 1):1712-7. doi: 10.1164/ajrccm.154.6.8970360.